From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine
Nicholas A Kerna, Kevin D. Pruitt, N.d. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets, John V. Flores, Ijeoma Nnake, Cornelius I. Azi, Joseph Anderson, Fatimah A. Olunlade, Uzoamaka Nwokorie
European Journal of Arts Humanities and Social Sciences May 1, 2024 Peer reviewed DOI: 10.59324/ejahss.2024.1(3).10 via OpenAlex
Summary
Entheogens, psychoactive substances with cultural and religious importance, have been used for healing and spiritual purposes across various traditions. They show potential therapeutic benefits for psychiatric disorders like depression, anxiety, and PTSD, but their use carries risks. The study highlights the need for rigorous research to explore their mechanisms of action and therapeutic applications while ensuring safety through proper administration and medical supervision.
Study at a glance
| Key finding | Entheogens demonstrate promising therapeutic effects for psychiatric disorders but also pose inherent risks that necessitate careful research and administration. |
|---|
Abstract
Entheogens, a class of psychoactive substances with profound cultural and religious significance, have been utilized for centuries across diverse traditions for healing, spiritual exploration, and communication with the divine. Their historical usage spans continents, from the pre-Columbian Americas to traditional African practices and Ayurvedic medicine in India. While entheogens offer potential therapeutic benefits, their use entails inherent risks, including physiological and psychological adverse effects. Recent research has increasingly focused on elucidating the mechanisms of action and therapeutic potential of entheogens such as psilocybin, N,N-dimethyltryptamine (DMT), mescaline, lysergic acid diethylamide (LSD), ayahuasca, ibogaine, and Salvia divinorum. These substances exhibit diverse pharmacological profiles, acting primarily on serotonin receptors and other neurotransmitter systems, resulting in alterations in perception, mood, and cognition. Clinical studies have demonstrated promising results for entheogens in the treatment of psychiatric disorders, including depression, anxiety, addiction, and post-traumatic stress disorder (PTSD), and, to a lesser extent, pain management and cluster headaches. However, regulatory constraints, limited participant numbers, and ethical considerations hinder comprehensive research. Safety considerations are paramount in administering entheogens, necessitating proper dosing, individual risk assessment, supportive set and setting, and medical supervision. Adherence to rigorous clinical trial standards and transparent methodologies is essential for advancing research and harnessing the therapeutic potential of entheogens. Despite obstacles, continued investigation into entheogens is imperative for unlocking their therapeutic potential and developing safe and effective mental health treatments. Key research avenues include elucidating mechanisms of action, standardizing administration protocols, determining optimal dosages, and assessing long-term effects and associated risks. While cannabis is commonly recognized as an entheogen, it was not encompassed in this review. The authors omitted it due to its unique status, ongoing discourse, and the need for a separate dedicated analysis.